These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 550149

  • 1. Platelet hyporesponsiveness to epinephrine in carriers of Bartter's syndrome.
    O'Regan S, Rivard GE, Cole C, Robitaille PO.
    Prostaglandins Med; 1979 May; 2(5):321-4. PubMed ID: 550149
    [Abstract] [Full Text] [Related]

  • 2. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
    O'Reagan SO, Rivard GE, Mongeau JG, Robitaille PO.
    Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
    [Abstract] [Full Text] [Related]

  • 3. Platelet aggregation in six families with Bartter's syndrome.
    Rodrigues Pereira R, Pereira RR.
    Clin Chim Acta; 1983 Jun 15; 130(3):363-8. PubMed ID: 6872267
    [Abstract] [Full Text] [Related]

  • 4. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin?
    MacIntyre DE, Smith M, Levine L, Stoff JS, Stemerman M, Steer ML, Salzman EW, Brown RS.
    Adv Prostaglandin Thromboxane Res; 1980 Jun 15; 7():1199-202. PubMed ID: 7369031
    [No Abstract] [Full Text] [Related]

  • 5. Inheritance of Bartter syndrome.
    Rodrigues Pereira R, van Wersch J.
    Am J Med Genet; 1983 May 15; 15(1):79-84. PubMed ID: 6859127
    [Abstract] [Full Text] [Related]

  • 6. A defect in platelet aggregation in Bartter's syndrome.
    Stoff JS, Stemerman M, Steer M, Salzman E, Brown RS.
    Am J Med; 1980 Feb 15; 68(2):171-80. PubMed ID: 6243857
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS, Somani P, Freimer EH.
    Clin Ther; 1989 Feb 15; 11(5):640-51. PubMed ID: 2629724
    [Abstract] [Full Text] [Related]

  • 8. [Blood glucose regulation in Bartter's syndrome. Observations in 2 cases].
    Uccella R, Agosti C, Morenghi R, Morgutti M.
    Minerva Med; 1983 Mar 10; 74(9-10):453-63. PubMed ID: 6340001
    [Abstract] [Full Text] [Related]

  • 9. [Determination of platelet aggregation using the KZM-1-R meter (aggregation inducers: ADP, collagen, ristocetin, ristomycin, adrenaline. Therapy control by use of acetylsalicylic acid)].
    Stepanauskas M, Norden C, Söllner P, Heine H.
    Z Med Lab Diagn; 1981 Mar 10; 22(3):148-54. PubMed ID: 6270924
    [No Abstract] [Full Text] [Related]

  • 10. Critical importance of citrate--blood ratio in platelet aggregation studies.
    Ts'ao CH, Lo R, Raymond J.
    Am J Clin Pathol; 1976 Apr 10; 65(4):518-22. PubMed ID: 1266813
    [Abstract] [Full Text] [Related]

  • 11. In vitro enhancement of human platelet aggregation by somatostatin.
    Gazzaniga PP, Di Macco G, La Mancusa R, Oddi A, Pappalardo G, Pulcinelli FM, Reggio D.
    Experientia; 1988 Oct 15; 44(10):892-4. PubMed ID: 2903069
    [Abstract] [Full Text] [Related]

  • 12. [Effect of heparin on platelet aggregation in vitro].
    Róka L, Isert D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Oct 15; 111(6):735-49. PubMed ID: 6083949
    [Abstract] [Full Text] [Related]

  • 13. Resistance to endogenous norepinephrine in Bartter's syndrome: reversion during indomethacin administration.
    Silverberg AB, Mennes PA, Cryer PE.
    Am J Med; 1978 Feb 15; 64(2):231-5. PubMed ID: 629272
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of an automated light transmission aggregometry.
    Ling LQ, Liao J, Niu Q, Wang X, Jia J, Zuo CH, Jiang H, Zhou J.
    Platelets; 2017 Nov 15; 28(7):712-719. PubMed ID: 28150526
    [Abstract] [Full Text] [Related]

  • 15. Platelet calmodulin concentration in essential hypertension and in Bartter's syndrome.
    Calò L, Cantaro S, Vianello A, Favaro S, Borsatti A.
    Am J Nephrol; 1986 Nov 15; 6 Suppl 1():60-2. PubMed ID: 3103446
    [No Abstract] [Full Text] [Related]

  • 16. Effect of captopril in Bartter's syndrome.
    Hené RJ, Koomans HA, Boer P, Dorhout Mees EJ.
    Nephron; 1983 Nov 15; 35(4):275. PubMed ID: 6358925
    [No Abstract] [Full Text] [Related]

  • 17. 6-keto-prostaglandin E1 and Bartter's syndrome.
    Jackson EK, Goodman RP.
    N Engl J Med; 1981 Jul 30; 305(5):287. PubMed ID: 7195465
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A.
    Platelets; 2009 Aug 30; 20(5):297-301. PubMed ID: 19548178
    [Abstract] [Full Text] [Related]

  • 19. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V, Heyns AD.
    Thromb Res; 1990 Feb 15; 57(4):601-9. PubMed ID: 2158153
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide in Bartter's syndrome.
    Yamada K, Tajima K, Moriwaki K, Tarui S, Miyata A, Kangawa K, Matsuo H.
    Lancet; 1986 Feb 01; 1(8475):273. PubMed ID: 2868282
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.